Evidence map›Paper›PMID 34663705›Full record

ArticleNeurosciences (Riyadh, Saudi Arabia)2021

Screening of dysphagia in relapsing-remitting multiple sclerosis patients in Montenegro.

Jevto Lj Eraković, Ljiljana B Radulović, Zilha A Idrizović, Milovan B Roganović

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurosciences (Riyadh, Saudi Arabia), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jevto Lj ErakovićFrom the Department of Neurology (Eraković, Radulović, Roganović), Clinical Centre of Montenegro, from the Faculty of Medicine (Radulović, Roganović), University of Montenegro, Podgorica, and from the Polyclinic Neuron (Idrizović), Bijelo Polje, Montenegro.
Ljiljana B RadulovićFrom the Department of Neurology (Eraković, Radulović, Roganović), Clinical Centre of Montenegro, from the Faculty of Medicine (Radulović, Roganović), University of Montenegro, Podgorica, and from the Polyclinic Neuron (Idrizović), Bijelo Polje, Montenegro.
Zilha A IdrizovićFrom the Department of Neurology (Eraković, Radulović, Roganović), Clinical Centre of Montenegro, from the Faculty of Medicine (Radulović, Roganović), University of Montenegro, Podgorica, and from the Polyclinic Neuron (Idrizović), Bijelo Polje, Montenegro.
Milovan B RoganovićFrom the Department of Neurology (Eraković, Radulović, Roganović), Clinical Centre of Montenegro, from the Faculty of Medicine (Radulović, Roganović), University of Montenegro, Podgorica, and from the Polyclinic Neuron (Idrizović), Bijelo Polje, Montenegro.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo perform screening of dysphagia in Montenegrin multiple sclerosis (MS) patients. Dysphagia is often neglected problem in patients with MS.

methodsWe included 104 patients with relapsing-remitting MS who completed 3 questionnaires: dysphagia in multiple sclerosis (DYMUS), eating assessment tool-10 (EAT-10) and swallowing disturbance questionnaire (SDQ). Our study was performed in the clinic for neurology of the Clinical Center of Montenegro (Podgorica, Montenegro) and Polyclinic Neuron (Bijelo Polje, Montenegro) between November 2020 and December 2020.

resultsSelf-reported prevalence of this symptom in our group was simmilar to previously reported results. We did not find correlation between DYMUS and expanded disability status scale (EDSS), as it was reported before. Time spent from disease onset to diagnosis is strongly correlated with reported SDQ results. The population of dysphagia-patients is statistically significantly older compared to the non-dysphagia patients, and statistically higher mean values in this population of our subjects were proven on all 3 questionnaires used.

conclusionThe importance of this issue is not just because it warns of potientially malnutrion in MS patients, but also important factor in therapy choosing algorithm in the era of orally used immunomodulatory drugs.

Indexed as

Deglutition DisordersMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingDisability EvaluationHumansImmunomodulating AgentsMontenegroImmunomodulating Agents

Identifiers

PMID34663705
PMCPMC9037765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.